Table 3.

Correlation between PRL and clinical parameters in all participants.

Parameters	PRL (all)		PRL (male)		PRL (female)
	r	P	r	P	r	P
Age	0.006	0.930	0.135	0.098	−0.123	0.056
BMI	−0.058	0.357	0.025	0.762	−0.076	0.465
WC	−0.141	0.032	−0.151	0.023	−0.138	0.045
HC	−0.137	0.324	−0.071	0.879	−0.173	0.319
SBP	−0.172	0.564	−0.194	0.431	−0.161	0.502
DBP	−0.086	0.787	−0.077	0.874	−0.090	0.773
TC	−0.076	0.221	0.113	0.167	−0.114	0.077
TG	−0.260	0.000	−0.162	0.008	−0.246	0.000
HDL-C	0.022	0.726	0.031	0.617	0.029	0.769
LDL-C	−0.093	0.135	−0.037	0.236	−0.095	0.139
NEFA	−0.222	0.002	−0.601	0.000	−0.290	0.012
FBG	−0.136	0.030	−0.132	0.043	−0.155	0.033
FINS	−0.080	0.225	−0.036	0.842	−0.120	0.134
HbA1c	−0.010	0.879	−0.112	0.172	0.056	0.400
hsCRP	−0.012	0.963	−0.003	0.982	−0.142	0.531
HOMA-IR	−0.244	0.000	−0.228	0.000	−0.232	0.000
adipo-IR	−0.302	0.000	−0.324	0.000	−0.296	0.000
Estradiol	−0.007	0.905	0.079	0.497	−0.093	0.181
TT	0.106	0.065	0.226	0.198	−0.104	0.187
TSH	0.143	0.037	0.174	0.033	0.240	0.000

Adipo-IR, adipose tissue insulin resistance; DBP, diastolic blood pressure; FBG, fasting blood glucose; FINS, fasting insulin; HbA1c, hemoglobin A1c; HC, hip circumference; HDL-C, high-density lipoprotein cholesterol; HOMA-IR, homeostasis model assessment of insulin resistance; hsCRP, high-sensitivity C-reactive protein; LDL-C, low-density lipoprotein cholesterol; NEFA, non-esterified fatty acid; PRL, prolactin; SBP, systolic blood pressure; TC, total cholesterol; TG, triglyceride; TSH, thyroid stimulating hormone; TT, total testosterone; WC, waist circumference.